Copyright
©The Author(s) 2018.
World J Hepatol. Jan 27, 2018; 10(1): 142-154
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.142
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.142
Table 3 Characteristics of patients’ studies for vitamin D status in non-alcoholic fatty liver disease
Citation | Patel et al[32] | Luger et al[30] | Barchetta et al[28] | Anty et al[27] | Dasarthy et al[24] | Bril et al[29] | Nelson et al[31] | Targher et al[26] |
Year | 2016 | 2016 | 2012 | 2016 | 2014 | 2015 | 2016 | 2007 |
Country | United States | Austria | Italy | France | United States | United States | United States | Italy |
Subjects (M, F) | 293 (195, 98) | 50 (10, 40) | 45 (22, 23) | 398 (64, 334) | 187 (51, 136) | 239 (204, 35) | 190 (89, 101) | 120 (80, 40) |
Population | Suspected NAFLD undergoing liver biopsy | Gastric bypass patients | Suspected NAFLD | Morbidly obese referred for bariatric surgery | Biopsy proven NAFLD, normal controls | Overweight patients | Biopsy proven NAFLD | Biopsy proven NAFLD |
Mean BMI | 36.1 ± 7.8 | 43.8 ± 4.3 | 30.5 ± 5.5 | 42.8 ± 5.0 | 35.7 ± 7.0 | 34.6 ± 0.4 | 35.6 ± 10.8 | 26.3 ± 2.0 |
Subjects | NAFLD | All | NASH | All | NAFLD | NASH | NAFLD | NAFLD |
Mean ± SD ALT IU/L | 66.5 ± 51.2 | 36.4 ± 20.8 | 87.5 ± 46.6 | 35.2 ± 24.5 | 45.9 ± 30.0 | 64.0 ± 4.0 | 77.0 ± 48.2 | 105 ± 42.0 |
Subjects | NAFLD | All | NASH | Morbidly Obese | NAFLD | NASH | NAFLD | NAFLD |
Study design | Cross sectional | Cross sectional | Cross sectional | Cross sectional | Cross sectional | Cross sectional | Cross sectional | Cross sectional |
Vitamin D analysis | CLIA | Not described | CLIA | CLIA | CLIA | CLIA | GC-MS | CLIA |
Mean/SD 25(OH)D (ng/mL), (n) subjects | 27.6 ± 11.8 | 15.6 ± 5.6 | 22.0 ± 12.4 | 19.2 ± 9.0 | 21.2 ± 10.4 | 21.8 ± 1.0 | 20.9 ± 4.0 | 20.4 ± 8.8 |
Mean/SD 25(OH)D (ng/mL) Non-NAFLD Controls | 27.9 ± 12.8 | NA | 52.9 ± 11.02 | 21.5 ± 10/2 | 35.7 ± 6.0 | 24.5 ± 2.1 | NA | 30.0 ± 6.0 |
P value; NAFLD vs controls | 0.878 | NA | Not significant | 0.13 | < 0.01 | 0.18 | NA | < 0.001 |
- Citation: Saberi B, Dadabhai AS, Nanavati J, Wang L, Shinohara RT, Mullin GE. Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A PRISMA compliant systematic review and meta-analysis of pooled data. World J Hepatol 2018; 10(1): 142-154
- URL: https://www.wjgnet.com/1948-5182/full/v10/i1/142.htm
- DOI: https://dx.doi.org/10.4254/wjh.v10.i1.142